|
|
|
|
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
|
Laporte Road, Stallingborough
|
|
|
|
Grimsby, North East Lincolnshire, DN40 2PR, UK
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Title of each class
|
Trading Symbol(s)
|
Name of exchange on which registered
|
|
|
|
|
| Item 2.02. |
Results of Operations and Financial Condition.
|
| Item 9.01. |
Financial Statements and Exhibits.
|
|
Exhibit
No.
|
Description
|
|
|
Press Release, dated April 27, 2022 reporting Tronox Holdings plc’s financial results for the first quarter
2022.
|
||
|
104
|
Inline XBRL for the cover page of this Current Report on Form 8-K.
|
|
TRONOX HOLDINGS PLC
|
|||
|
Date: April 28, 2022
|
By:
|
/s/ Jeffrey N. Neuman
|
|
|
Name:
|
Jeffrey N. Neuman
|
||
|
Title:
|
Senior Vice President, General Counsel and Secretary
|
||
| • |
Produced revenue of $965 million, an increase of 8% compared to the prior year, primarily driven by higher revenue from
TiO2 and pig iron
|
| • |
Generated income from operations of $69 million and net income of $16 million, inclusive of a one-time fee regarding the settlement agreement reached with Venator totaling $85 million including the break fee and
related negotiated interest
|
| • |
Achieved GAAP diluted EPS of $0.10; adjusted diluted EPS of $0.60 (non-GAAP) primarily due to the settlement
|
| • |
Delivered Adjusted EBITDA of $240 million, within the guided range, and an Adjusted EBITDA margin of 24.9%
|
| • |
Invested $103 million in capital expenditures and generated free cash flow of $86 million
|
| • |
Reaffirming 2022 Adjusted EBITDA and adjusted diluted EPS guidance; adjusting 2022 free cash flow lower largely to reflect the settlement
|
|
($M unless otherwise noted)
|
Q1 2022
|
Q1 2021
|
Y-o-Y % ∆
|
|
Q4 2021
|
Q-o-Q % ∆
|
|
|||||||||||||
|
Revenue
|
$
|
965
|
$
|
891
|
8
|
%
|
$
|
884
|
9
|
%
|
||||||||||
|
TiO2
|
$
|
773
|
$
|
696
|
11
|
%
|
$
|
675
|
15
|
%
|
||||||||||
|
Zircon
|
$
|
108
|
$
|
123
|
(12
|
)%
|
$
|
119
|
(9
|
)%
|
||||||||||
|
Feedstock and other products
|
$
|
84
|
$
|
72
|
17
|
%
|
$
|
91
|
(8
|
)%
|
||||||||||
|
Income from operations
|
$
|
69
|
$
|
125
|
(45
|
)%
|
$
|
134
|
(49
|
)%
|
||||||||||
|
Net Income
|
$
|
16
|
$
|
26
|
(38
|
)%
|
$
|
87
|
(82
|
)%
|
||||||||||
|
Net Income attributable to Tronox
|
$
|
16
|
$
|
19
|
(16
|
)%
|
$
|
83
|
(81
|
)%
|
||||||||||
|
GAAP diluted earnings per share
|
$
|
0.10
|
$
|
0.12
|
(17
|
)%
|
$
|
0.52
|
(81
|
)%
|
||||||||||
|
Adjusted diluted earnings per share
|
$
|
0.60
|
$
|
0.43
|
40
|
%
|
$
|
0.53
|
13
|
%
|
||||||||||
|
Adjusted EBITDA
|
$
|
240
|
$
|
225
|
7
|
%
|
$
|
233
|
3
|
%
|
||||||||||
|
Adjusted EBITDA Margin %
|
24.9
|
%
|
25.3
|
%
|
(40) bps
|
26.4
|
%
|
(150) bps
|
||||||||||||
|
Free cash flow
|
$
|
86
|
$
|
77
|
12
|
%
|
$
|
50
|
72
|
%
|
||||||||||
|
Y-o-Y % ∆
|
Q-o-Q % ∆
|
|||||||||||||||||||
|
Volume
|
Price
|
Volume
|
Price
|
|||||||||||||||||
|
TiO2
|
(6
|
)%
|
18
|
%
|
9
|
%
|
6
|
%
|
||||||||||||
|
Local Currency Basis
|
n/a
|
20
|
%
|
n/a
|
6
|
%
|
||||||||||||||
|
Zircon
|
(38
|
)%
|
43
|
%
|
(20
|
)%
|
14
|
%
|
||||||||||||
| • |
FY 2022:
|
| ◦ |
Reaffirming Adjusted EBITDA guided range at $1.025-$1.125 billion
|
| ◦ |
Reaffirming Adjusted diluted EPS guided range at $3.08 to $3.591
|
| ◦ |
Adjusting free cash flow expectation lower to at least $265 million, reflecting the settlement ($85 million), increased 2022 capital expenditures ($25 million) and increased working capital requirements ($25
million)
|
| • |
Q2 2022: Adjusted EBITDA expected to be $265-280 million
|
| 1. |
Assumes a corporate effective tax rate of approximately 20%, which may vary depending on jurisdiction of earnings and tax assets.
|
|
Three Months Ended March 31,
|
||||||||
|
2022
|
2021
|
|||||||
|
Net sales
|
$
|
965
|
$
|
891
|
||||
|
Cost of goods sold
|
733
|
685
|
||||||
|
Gross profit
|
232
|
206
|
||||||
|
Selling, general and administrative expenses
|
78
|
81
|
||||||
|
Venator settlement
|
85
|
-
|
||||||
|
Income from operations
|
69
|
125
|
||||||
|
Interest expense
|
(32
|
)
|
(50
|
)
|
||||
|
Interest income
|
2
|
1
|
||||||
|
Loss on extinguishment of debt
|
(1
|
)
|
(34
|
)
|
||||
|
Other expense, net
|
(4
|
)
|
(10
|
)
|
||||
|
Income before income taxes
|
34
|
32
|
||||||
|
Income tax provision
|
(18
|
)
|
(6
|
)
|
||||
|
Net income
|
16
|
26
|
||||||
|
Net income attributable to noncontrolling interest
|
-
|
7
|
||||||
|
Net income attributable to Tronox Holdings plc
|
$
|
16
|
$
|
19
|
||||
|
Earnings per share:
|
||||||||
|
Basic
|
$
|
0.10
|
$
|
0.13
|
||||
|
Diluted
|
$
|
0.10
|
$
|
0.12
|
||||
|
Weighted average shares outstanding, basic (in thousands)
|
154,629
|
147,071
|
||||||
|
Weighted average shares outstanding, diluted (in thousands)
|
159,577
|
153,928
|
||||||
|
Other Operating Data:
|
||||||||
|
Capital expenditures
|
103
|
58
|
||||||
|
Depreciation, depletion and amortization expense
|
68
|
84
|
||||||
|
Three Months Ended March 31,
|
||||||||
|
2022
|
2021
|
|||||||
|
Net income (loss) attributable to Tronox Holdings plc (U.S. GAAP)
|
$
|
16
|
$
|
19
|
||||
|
Venator settlement (a)
|
85
|
-
|
||||||
|
Loss on extinguishment of debt (b)
|
1
|
26
|
||||||
|
Severance charges (c)
|
1
|
-
|
||||||
|
Transaction costs (d)
|
-
|
18
|
||||||
|
Gain on asset sale (e)
|
-
|
(2
|
)
|
|||||
|
Costs associated with former CEO retirement (f)
|
-
|
3
|
||||||
|
Costs associated with Exxaro deal (g)
|
-
|
1
|
||||||
|
Income tax expense - deferred tax assets (h)
|
(7
|
)
|
-
|
|||||
|
Other (i)
|
-
|
1
|
||||||
|
Adjusted net income attributable to Tronox Holdings plc (non-U.S. GAAP) (1)
|
$
|
96
|
$
|
66
|
||||
|
Diluted net income (loss) per share (U.S. GAAP)
|
$
|
0.10
|
$
|
0.12
|
||||
|
Venator settlement, per share
|
0.53
|
-
|
||||||
|
Loss on extinguishment of debt, per share
|
0.01
|
0.17
|
||||||
|
Severance charges, per share
|
0.01
|
-
|
||||||
|
Transaction costs, per share
|
-
|
0.12
|
||||||
|
Gain on asset sale, per share
|
-
|
(0.01
|
)
|
|||||
|
Costs associated with former CEO retirement, per share
|
-
|
0.02
|
||||||
|
Costs associated with Exxaro deal, per share
|
-
|
0.01
|
||||||
|
Income tax expense - deferred tax assets, per share
|
(0.04
|
)
|
-
|
|||||
|
Other, per share
|
-
|
0.01
|
||||||
|
Diluted adjusted net income per share attributable to Tronox Holdings plc (non-U.S. GAAP) (2)
|
$
|
0.60
|
$
|
0.43
|
||||
|
Weighted average shares outstanding, diluted (in thousands)
|
159,577
|
153,928
|
||||||
|
March 31, 2022
|
December 31, 2021
|
|||||||
|
ASSETS
|
||||||||
|
Current Assets
|
||||||||
|
Cash and cash equivalents
|
$
|
292
|
$
|
228
|
||||
|
Restricted cash
|
4
|
4
|
||||||
|
Accounts receivable (net of allowance for credit losses of $4 million and $4 million as of March 31, 2022 and December 31, 2021,
respectively)
|
651
|
631
|
||||||
|
Inventories, net
|
1,050
|
1,048
|
||||||
|
Prepaid and other assets
|
187
|
132
|
||||||
|
Income taxes receivable
|
5
|
6
|
||||||
|
Total current assets
|
2,189
|
2,049
|
||||||
|
Noncurrent Assets
|
||||||||
|
Property, plant and equipment, net
|
1,770
|
1,710
|
||||||
|
Mineral leaseholds, net
|
763
|
747
|
||||||
|
Intangible assets, net
|
229
|
217
|
||||||
|
Lease right of use assets, net
|
86
|
85
|
||||||
|
Deferred tax assets
|
981
|
985
|
||||||
|
Other long-term assets
|
197
|
194
|
||||||
|
Total assets
|
$
|
6,215
|
$
|
5,987
|
||||
|
LIABILITIES AND EQUITY
|
||||||||
|
Current Liabilities
|
||||||||
|
Accounts payable
|
$
|
490
|
$
|
438
|
||||
|
Accrued liabilities
|
377
|
328
|
||||||
|
Short-term lease liabilities
|
22
|
26
|
||||||
|
Long-term debt due within one year
|
16
|
18
|
||||||
|
Income taxes payable
|
18
|
12
|
||||||
|
Total current liabilities
|
923
|
822
|
||||||
|
Noncurrent Liabilities
|
||||||||
|
Long-term debt, net
|
2,567
|
2,558
|
||||||
|
Pension and postretirement healthcare benefits
|
117
|
116
|
||||||
|
Asset retirement obligations
|
146
|
139
|
||||||
|
Environmental liabilities
|
66
|
66
|
||||||
|
Long-term lease liabilities
|
61
|
55
|
||||||
|
Deferred tax liabilities
|
176
|
157
|
||||||
|
Other long-term liabilities
|
30
|
32
|
||||||
|
Total liabilities
|
4,086
|
3,945
|
||||||
|
Commitments and Contingencies
|
||||||||
|
Shareholders’ Equity
|
||||||||
|
Tronox Holdings plc ordinary shares, par value $0.01 — 155,797,426 shares issued and outstanding at March 31, 2022 and 153,934,677
shares issued and outstanding at December 31, 2021
|
2
|
2
|
||||||
|
Capital in excess of par value
|
2,049
|
2,067
|
||||||
|
Retained earnings
|
659
|
663
|
||||||
|
Accumulated other comprehensive loss
|
(637
|
)
|
(738
|
)
|
||||
|
Total Tronox Holdings plc shareholders’ equity
|
2,073
|
1,994
|
||||||
|
Noncontrolling interest
|
56
|
48
|
||||||
|
Total equity
|
2,129
|
2,042
|
||||||
|
Total liabilities and equity
|
$
|
6,215
|
$
|
5,987
|
||||
|
Three Months Ended March 31,
|
||||||||
|
2022
|
2021
|
|||||||
|
Cash Flows from Operating Activities:
|
||||||||
|
Net income
|
$
|
16
|
$
|
26
|
||||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
|
Depreciation, depletion and amortization
|
68
|
84
|
||||||
|
Deferred income taxes
|
4
|
(3
|
)
|
|||||
|
Share-based compensation expense
|
7
|
9
|
||||||
|
Amortization of deferred debt issuance costs and discount on debt
|
2
|
3
|
||||||
|
Loss on extinguishment of debt
|
1
|
34
|
||||||
|
Venator settlement
|
85
|
-
|
||||||
|
Other non-cash items affecting net income
|
2
|
14
|
||||||
|
Changes in assets and liabilities:
|
||||||||
|
Increase in accounts receivable, net of allowance for credit losses
|
(11
|
)
|
(120
|
)
|
||||
|
Decrease in inventories, net
|
21
|
63
|
||||||
|
(Increase) decrease in prepaid and other assets
|
(17
|
)
|
32
|
|||||
|
Increase in accounts payable and accrued liabilities
|
18
|
2
|
||||||
|
Net changes in income tax payables and receivables
|
7
|
7
|
||||||
|
Changes in other non-current assets and liabilities
|
(14
|
)
|
(16
|
)
|
||||
|
Cash provided by operating activities
|
189
|
135
|
||||||
|
Cash Flows from Investing Activities:
|
||||||||
|
Capital expenditures
|
(103
|
)
|
(58
|
)
|
||||
|
Insurance proceeds
|
-
|
1
|
||||||
|
Proceeds from sale of assets
|
1
|
-
|
||||||
|
Cash used in investing activities
|
(102
|
)
|
(57
|
)
|
||||
|
Cash Flows from Financing Activities:
|
||||||||
|
Repayments of long-term debt
|
(3
|
)
|
(2,260
|
)
|
||||
|
Proceeds from long-term debt
|
-
|
2,375
|
||||||
|
Repurchase of common stock
|
(25
|
)
|
-
|
|||||
|
Call premiums paid
|
-
|
(21
|
)
|
|||||
|
Debt issuance costs
|
-
|
(30
|
)
|
|||||
|
Dividends paid
|
(1
|
)
|
(14
|
)
|
||||
|
Restricted stock and performance-based shares settled in cash for withholding taxes
|
-
|
(2
|
)
|
|||||
|
Cash (used in) provided by financing activities
|
(29
|
)
|
48
|
|||||
|
Effects of exchange rate changes on cash and cash equivalents and restricted cash
|
6
|
(7
|
)
|
|||||
|
Net increase in cash, cash equivalents and restricted cash
|
64
|
119
|
||||||
|
Cash, cash equivalents and restricted cash at beginning of period
|
232
|
648
|
||||||
|
Cash, cash equivalents and restricted cash at end of period
|
$
|
296
|
$
|
767
|
||||
|
Three Months Ended March 31,
|
||||||||
|
2022
|
2021
|
|||||||
|
Net income (U.S. GAAP)
|
$
|
16
|
$
|
26
|
||||
|
Interest expense
|
32
|
50
|
||||||
|
Interest income
|
(2
|
)
|
(1
|
)
|
||||
|
Income tax provision
|
18
|
6
|
||||||
|
Depreciation, depletion and amortization expense
|
68
|
84
|
||||||
|
EBITDA (non-U.S. GAAP)
|
132
|
165
|
||||||
|
Share-based compensation (a)
|
7
|
9
|
||||||
|
Transaction costs (b)
|
-
|
18
|
||||||
|
Venator settlement (c)
|
85
|
-
|
||||||
|
Loss on extinguishment of debt (d)
|
1
|
34
|
||||||
|
Costs associated with former CEO retirement (e)
|
-
|
1
|
||||||
|
Gain on asset sale (f)
|
-
|
(2
|
)
|
|||||
|
Foreign currency remeasurement (g)
|
8
|
(4
|
)
|
|||||
|
Costs associated with Exxaro deal (h)
|
-
|
1
|
||||||
|
Other items (i)
|
7
|
3
|
||||||
|
Adjusted EBITDA (non-U.S. GAAP)
|
$
|
240
|
$
|
225
|
||||
|
Consolidated
|
||||
|
Cash provided by operating activities
|
$
|
189
|
||
|
Capital expenditures
|
(103
|
)
|
||
|
Free cash flow (non-U.S. GAAP)
|
$
|
86
|
||